## IQV: IQVIA Holdings, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -2.5% below STRENGTH zone (3.0-6.0%); PEG 1.05 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($213.83)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Panagora Asset Management Inc. Acquires 80,323 Shares of IQVIA Holdings Inc. $IQV**
- Source: MarketBeat | 20251204T120954 | Somewhat-Bullish | Relevance: 100%
-  Panagora Asset Management Inc. significantly increased its stake in IQVIA Holdings Inc. (NYSE:IQV) by acquiring an additional 80,323 shares, raising its total holdings to 87,917 shares valued at $13.86 million. This move comes alongside other institutional investment changes and a recent insider stock sale by Eric Sherbet. Analyst sentiment remains generally positive for IQVIA, with an average "Moderate Buy" rating and a target price of $241.44.

**2. Is IQVIA Holdings Stock Outperforming the S&P 500?**
- Source: Barchart.com | 20251204T035407 | Bullish | Relevance: 99%
- IQVIA Holdings Inc. (IQV) is a large-cap company providing clinical research and healthcare intelligence. The stock has outperformed the S&P 500 over the past three months and analysts rate it a "Strong Buy." Despite lagging the broader market over the past year, IQVIA reported strong Q3 results, beating revenue and EPS expectations.

**3. M&T Bank Corp Lowers Position in IQVIA Holdings Inc. $IQV**
- Source: MarketBeat | 20251205T114746 | Neutral | Relevance: 98%
-  M&T Bank Corp recently reduced its stake in IQVIA Holdings Inc. (NYSE:IQV) by 13.0% in the second quarter, now owning 32,273 shares valued at $5.086 million. Despite this reduction, other institutional investors have significantly increased their positions in IQVIA, with the companyâ€™s stock trading down 1.1% on Friday. Analysts currently rate IQVIA with a "Moderate Buy" and an average price target of $241.44.

**4. IQVIA (IQV) Stock: Q3 2025 Results, 23% 3-Month Surge, and Analyst Outlook - News and Statistics**
- Source: IndexBox | 20251204T071117 | Bullish | Relevance: 98%
-  IQVIA Holdings Inc. (IQV) is trading 3% below its 52-week high after reporting strong Q3 2025 financial results, with revenue up 5.2% and adjusted EPS up 5.6% year-over-year. The stock has surged 23.1% in the past three months, outperforming the S&P 500, and analysts have a "Strong Buy" consensus rating with a 7.4% upside potential.

**5. Is IQVIA Holdings Stock Outperforming the S&P 500?**
- Source: Markets Financial Content | 20251204T033200 | Bullish | Relevance: 98%
- IQVIA Holdings Inc. (IQV) has shown strong performance in the short term, with its stock soaring 23.1% over the past three months, outperforming the S&P 500's 6.2% gains. The company, valued at $38.4 billion, exceeded Q3 earnings expectations and boasts a "Strong Buy" consensus rating from analysts. While slightly lagging the broader market over longer periods, IQV demonstrates a bullish trend and significant upside potential.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $265 | $250 | +6% |
| 2025-11-13 | BMO Capital | $260 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Overweight |
| 2025-11-13 | BMO Capital | init | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($1.46M) |
| Sells | 1 ($5.78M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.4% (-0.9%)
- Blackrock Inc.: 8.7% (+4.5%)
- Harris Associates L.: 6.7% (-3.1%)
- State Street Corpora: 4.4% (-1.0%)
- JPMORGAN CHASE & CO: 3.9% (+110.0%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-2.2% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $5.8M in recent transactions.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.05 suggests fair value with growth premium. Forward P/E 17.5x stretched relative to 9% growth. Analyst sentiment positive (1 raises, avg +6%). Insider selling cluster ($5.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.1B |
| Beta | 1.37 |
| 52W Range | $134.65 - $234.30 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.05 |
| Forward P/E | 17.5 |
| Current P/E | 19.0 |
| YoY Growth | 8.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.3% to -2.5% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.5pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.52% (CS: 27) | Weak |
| RSI_14 | 58.5 | Neutral |
| MACD Histogram | -0.45 | Bearish |
| vs SMA20 | 1.014x | Above |
| vs SMA50 | 1.058x | Above |
| vs SMA200 | 1.251x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $225.85
- **Stop Loss:** $213.83 (5.3% risk)
- **Target:** $237.87 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 41
- **Position Value:** $9,259.85
- **Portfolio %:** 9.26%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite persisting. Mixed earnings signals with industrial weakness (John Deere) offset by consumer/tech strength, while institutional flows show selective positioning rather than broad risk-off. Fed meeting in 9 days provides near-term catalyst but current data suggests status quo maintenance.*

### Earnings

**Next:** 2026-02-05 (Est: $3.40)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.98 | $3.00 | +0.8% |
| 2025Q2 | $2.77 | $2.81 | +1.4% |
| 2025Q1 | $2.63 | $2.70 | +2.6% |
| 2024Q4 | $3.11 | $3.12 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*